Fortis Cancer Summit Bengaluru sets the stage for groundbreaking advances in precision oncology care

Inaugural Fortis Cancer Summit in Bangalore Ushers in Precision Oncology Era with Chief Guest, Karnataka's Health Minister Sri Dinesh Gundu Rao

Fortis Cancer Summit Bengaluru sets the stage for groundbreaking advances in precision oncology care
L-R: Dr Ritu Garg, Chief Growth & Innovation Officer, Fortis Healthcare, Dr Niti Raizada, Senior Director - Medical & Hemato-Oncology, Fortis Hospitals, Bengaluru and Organising Chairperson, Fortis Cancer Summit 2024, Dr Prem Kumar Nair, Group Chief Executive Officer, IHH Healthcare, Dr Ashutosh Raghuvanshi, MD & CEO, Fortis Healthcare, Honourable Health Minister of Karnataka, Shri Dinesh Gundu Rao, Dr Anil Vinayak, Group COO, Fortis Healthcare, Dr Bishnu Panigrahi, Group Head - Medical Strategy

Bengaluru, January 27, 2024: Fortis Healthcare is thrilled to announce the successful inauguration of the Fortis Cancer Summit, starting today at the Sheraton Grand Bangalore Hotel, at Brigade Gateway. This transformative event centred around the theme ‘Practice Changing Advances in Precision Oncology’, is aimed to revolutionize cancer treatment by showcasing innovations across the entire spectrum of cancer care. The formal inauguration at 11:00 AM today was graced by eminent dignitaries: the  Health Minister of Karnataka, Dinesh Gundu Rao, as the Chief Guest, and Dr. Prem Kumar Nair, Group CEO - IHH, as the Guest of Honour.
 

Accredited as a Continuing Medical Education (CME) event, the summit aims to highlight advancements across the entire continuum of cancer care, including screening, diagnostics, prognostics, therapeutics, homecare, and end-of-life care. The summit is anticipated to serve as a dynamic confluence of ideas, experiences, and pioneering innovations, poised to drive a transformative shift in the realm of cancer treatment and research.
 

The Fortis Cancer Summit has brought together a gathering of over 800 specialists and faculty members from both national and international spheres, featuring more than 250 experts specializing in various oncological disciplines. These professionals, representing Fortis Cancer Institutes and other esteemed centres, will be actively engaged over the 2-day event for collaborative sessions, delving into discussions about the latest advancements in diagnostic tools and therapeutic oncology innovations.
 

The summit will focus on delving into the forefront of cancer research and studies conducted throughout 2023 across a diverse spectrum of cancer types. The discussions will be on the latest advancements in emerging therapies, encompassing Artificial Intelligence in Precision Oncology, Immunotherapy, Targeted Therapies, Liquid Biopsy, CAR-T Cell Therapy, and Radio Molecular Theragnostic. It also provides a platform for young researchers and clinicians from various regions to contribute to cancer care innovation.
 

On the inauguration, the  Health Minister of Karnataka, Sri Dinesh Gundu Rao, said, “As we gather all doctors and healthcare professionals at the Fortis Cancer Summit, we foster crucial discussions on improving practices to combat the prevalent disease of cancer. Understanding its rise due to changing lifestyles affecting even the youth, we, as a government, emphasize early detection. Cancer takes a toll on individuals and families, prompting our focus on support, screening, and utilizing new technologies. Overcoming stigma in rural areas is a challenge, but advancements like AI can contribute to early detection solutions. Every life saved matters, urging stakeholders to unite in harnessing AI and technology for early detection, a crucial step in addressing various cancers beyond our current scope. The vast amount of medical data available holds immense research potential. As a government, we stand committed to supporting such endeavours in India, a knowledge hub. Congratulations to Fortis for organizing a summit that facilitates knowledge sharing, paving the way for effective solutions in the field of cancer.”
 

Dr. Prem Kumar Nair, Group CEO - IHH, expressed, “It’s an absolute privilege to be a part of the Fortis Cancer Summit, where I am witnessing the extraordinary dedication and innovation propelling cancer care forward. This summit serves as a powerful demonstration of our collective commitment to revolutionising cancer treatment through collaboration and cutting-edge research. I am deeply inspired by the tireless efforts of healthcare professionals and researchers gathered here, all striving to redefine the landscape of cancer care. The insights shared and collaborations formed during this event hold immense promise for the future of oncology. Together, we are paving the way for significant advancements in cancer treatment, ensuring that patients receive the best possible care and outcomes. I am deeply honoured to contribute to this transformative journey and eagerly anticipate the positive impact it will bring to cancer patients worldwide."
 

Dr. Ashutosh Raghuvanshi, MD & CEO, Fortis Healthcare, emphasised, “The Fortis Cancer Summit holds a special place in our hearts as it reflects our unwavering commitment to advancing cancer care through precision oncology. This summit marks a pivotal juncture in Fortis Healthcare's journey, signifying our dedication to leading advancements in cancer treatment and research. By bringing together some of the brightest minds in oncology, our aim is to cultivate an environment of innovation and collaboration, charting the course for the future of cancer care. Looking ahead, we remain steadfast in our commitment to pioneering breakthroughs and shaping the landscape of oncology to ensure a brighter and healthier future for all."
 

Dr. Niti Raizada, Senior Director – Medical & Hemato-Oncology, Fortis Hospitals, Bengaluru and Organising Chairperson, Fortis Cancer Summit, expressed, "The summit signifies a significant stride in redefining cancer care. Our commitment to precision oncology, incorporating advancements like AI and groundbreaking therapies, reflects a pursuit of excellence in cancer treatment. Beyond a mere event, the summit is a forward-looking movement towards reshaping oncology through personalized care. It fills us with pride, representing a substantial contribution to the dynamic landscape of oncology. I’m looking forward to the invigorating discussions and debates that will empower clinicians and foster innovation. The summit serves as a testament to our dedication to advancing cancer care and shaping a transformative future in the field.”